Within the previous Twenty Years, consumer advertising of prescription drugs has actually grown from a rarity to among the most prevalent kinds of consumer advertising, with advertisements for antidepressants and heart medications now as typical as those for junk food and vehicles. At the exact same time, direct-to-consumer (DTC) advertising has actually brought in a growing chorus of criticism from consumer supporters, health specialists, and chosen authorities.
This post checks out the degree to which such criticism has benefit and the degree to which it does not have stability. Particularly, the post calls into question the charges that (1) DTC advertising is misleading; (2) DTC minimizes item threats; (3) DTC concentrates on imaginary or minor ailments; (4) DTC does not promote non-pharmaceutical options to health issue; (5) DTC hurts the doctor-patient relationship; and (6) DTC is accountable for the fast increase in drug expenses.
PUBLICATION DATE: March 15, 2010 PRODUCT #: BH382-HCB-ENG
This is just an excerpt. This case is about SALES & MARKETING
Related Case Solutions & Analyses:
Chattanooga Ice Cream Division
Training Young Professionals in a Company
Hansson Private Label Inc.: Evaluating an Investment in Expansion
USAA in the Digital World
The Swatch Group
Roger Caracappa: Package Deals for the Estee Lauder Companies
Win the Brand Relevance Battle and then Build Competitor Barriers
Bombardier (A): The Procurement Decision of Light Rail Cars for the Los Angeles Metro Transit Authority
Out of this World: A Case for Martian Expansion
Clean and Abundant? A Case for a Hydrogen Economy
